Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
CAMTEK LTD.
(Translation of Registrants Name into English)
Ramat Gavriel Industrial Zone
P.O. Box 544
Migdal Haemek 23150
ISRAEL
(Address of Principal
Corporate Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities and Exchange Act of 1934.
Yes o No x
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CAMTEK LTD. (Registrant) By: /s/ Ronit Dulberg Ronit Dulberg, Chief Financial Officer |
Dated: November 13, 2006
2
Revenues $26.3 Million; Gross Profit $14 million; Net Income $4.2 million |
Reaffirming 2006 Revenue Guidance |
MIGDAL HAEMEK, Israel, November 9, 2006 - Camtek Ltd. (NASDAQ: CAMT; TASE: CAMT), today announced financial results for the third quarter ended September 30, 2006.
Revenues for the third quarter of 2006 were $26.3 million, 48% above $17.7 million in the third quarter of 2005, and sequentially 6% below the $27.9 million reported in the second quarter of 2006.
Gross profit margin for the third quarter of 2006 was 53.2%, compared to 48.5% for the third quarter of 2005, and 54.6% for the second quarter of 2006.
The Company reported third quarter net income of $4.2 million, or $0.13 per diluted share, compared to a net income of $1.5 million, or $0.06 per diluted share, in the third quarter of last year, and $5.2 million, or $0.17 per diluted share, in the second quarter of 2006.
We are excited about our further progress toward achieving our revenue goal for this year, commented Rafi Amit, Camteks CEO. This quarters results reaffirm that we are well poised to achieve that ambitious target. Based on our current view of our markets, we expect revenues in the next quarter to come within 5% of the third quarter revenue level, bringing Camteks expected annual growth to 65%-70% over 2005 revenues. Furthermore, we have supported the expansion of our organization without sacrificing our profitability.
Mr. Amit continued, Sales of Falcon, our wafer inspection systems for the semiconductor manufacturing and packaging industries, continued to be strong, with repeat orders from key customers and multiple orders from Asian facilities. We also added new strategic customers such as Samsung Electro Mechanics of Korea. We believe that the same factors that catapulted the Falcon sales in the past two years will continue to drive it ahead in the foreseeable future. To maintain and expand our competitive edge, we enhanced the Falcons 3D capabilities, advancing our leadership position in the bumped wafer 3D metrology market. We also augmented the Falcons compatibility with factory automation environment with the successful implementation of the SECS/GEM communication protocols, which opens the door to new customers.
In the PCB and HDI-S inspection arena, we are planning to launch several new products in the coming months. These new products approach new segments and maintain our technology leadership position. One new Pegasus model is currently undergoing customers evaluations with promising results. We anticipate the contribution of these products to our revenues in the coming quarters, concluded Mr. Amit.
more
3
Camtek will hold a conference call today, Thursday November 9, 2006 at 9:00 a.m. EST (for other time zones see below). Rafi Amit, Chief Executive Officer, Ronit Dulberg, Chief Financial Officer, and Yuval Attias, Director of finance, will host the call and will be available to answer questions after presenting the results.
To participate, please call one of the following telephone numbers at least 10 minutes before the start of the call.
US: | 1 866 527 8676 | at 9:00 a.m. EST |
UK: | 0 800 917 4613 | at 2:00 p.m. UK time |
Israel: | 03 918 0694 | at 4:00 p.m. Israel time |
International: | +972 3 918 0694 |
For those unable to participate, the teleconference will be available for replay on Camteks website at http://www.camtek.co.il/ beginning 24 hours after the call.
With headquarters in Migdal HaEmek Israel, Camtek Ltd., designs, develops, manufactures, and markets automatic optical inspection systems and related products. Camteks automatic inspection systems are used to enhance both production processes and yield for manufacturers in the printed circuit board industry, the high density interconnect substrate industry and the semiconductor manufacturing and packaging industry. This press release is available at www.camtek.co.il.
This press release may contain projections or other forward-looking statements regarding future events or the future performance of the Company. These statements are only predictions and may change as time passes. We do not assume any obligation to update that information. Actual events or results may differ materially from those projected, including as a result of changing industry and market trends, reduced demand for our products, the timely development of our new products and their adoption by the market, increased competition in the industry, price reductions as well as due to risks identified in the documents filed by the Company with the Securities and Exchange Commission.
CONTACT INFORMATION | ||
---|---|---|
CAMTEK: | IR/PR ISRAEL | IR INTERNATIONAL |
Ronit Dulberg, CFO | Financial Communication | Ehud Helft / Kenny Green |
Tel: +972-4-604-8308 | Noam Yellin | GK Investor Relations |
Fax: +972-4-604 8300 | Tel: +972 3 6954333 | Tel: (US) 1 866 704 6710 |
Mobile: +972-54-905-0776 | Fax: +972 544 246720 | kenny@gkir.com |
ronitd@camtek.co.il | ehud@gkir.com |
4
CAMTEK LTD.
Consolidated Balance Sheets
(in thousands, except share data)
September 30, |
December 31, | |||||||
---|---|---|---|---|---|---|---|---|
2006 |
2005 | |||||||
(Unaudited) |
(Audited) | |||||||
ASSETS | ||||||||
CURRENT ASSETS | ||||||||
Cash and cash equivalents | 27,249 | 8,714 | ||||||
Marketable securities | 2,100 | 2,101 | ||||||
Accounts receivable, net | 31,508 | 26,412 | ||||||
Inventories | 39,336 | 24,942 | ||||||
Due from affiliates | - | 290 | ||||||
Other current assets | 4,276 | 2,817 | ||||||
Total current assets | 104,469 | 65,276 | ||||||
Fixed assets, net | 10,432 | 9,963 | ||||||
Intangible assets, net | 30 | - | ||||||
Total assets | 114,931 | 75,239 | ||||||
LIABILITIES | ||||||||
CURRENT LIABILITIES | ||||||||
Accounts payable -trade | 14,740 | 8,678 | ||||||
Due to affiliates | 433 | - | ||||||
Other current liabilities | 12,500 | 8,721 | ||||||
Total current liabilities | 27,673 | 17,399 | ||||||
Convertible loan | 5,000 | 5,000 | ||||||
Accrued severance pay, net of amounts funded | 222 | 222 | ||||||
Total liabilities | 32,895 | 22,621 | ||||||
SHAREHOLDERS' EQUITY | ||||||||
Ordinary shares NIS 0.01 par value, authorized 100,000,000 shares, | ||||||||
issued 28,095,516 in 2005 and 31,023,214 in 2006, outstanding | ||||||||
27,083,897 in 2005 and 30,011,595 in 2006 | 131 | 125 | ||||||
Additional paid-in capital | 59,084 | 43,732 | ||||||
Deferred stock-based compensation | - | (221 | ) | |||||
Accumulated other comprehensive income (loss) | ||||||||
Unrealized income (loss) on marketable securities | 9 | (2 | ) | |||||
Retained earnings | 23,805 | 9,977 | ||||||
Treasury stock, at cost (1,011,619 shares in 2005 and 2006) | (993 | ) | (993 | ) | ||||
82,036 | 52,618 | |||||||
Total liabilities and shareholders' equity | 114,931 | 75,239 | ||||||
5
CAMTEK LTD.
Consolidated Statements of Operations
(in thousands, except share data)
Nine months ended September 30, |
Three months ended September 30, |
Year ended December 31, |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006 |
2005 |
2006 |
2005 |
2005 | |||||||||||||
(Unaudited) |
(Unaudited) |
(Unaudited) |
(Unaudited) |
(Audited) | |||||||||||||
Revenues | 79,049 | 43,649 | 26,293 | 17,737 | 63,032 | ||||||||||||
Cost of revenues | 36,776 | 22,999 | 12,299 | 9,190 | 32,781 | ||||||||||||
Gross Profit | 42,273 | 20,650 | 13,994 | 8,547 | 30,251 | ||||||||||||
Research and development costs | 8,169 | 6,188 | 3,275 | 2,326 | 8,469 | ||||||||||||
Selling, general and administrative expenses | 19,730 | 13,527 | 6,207 | 4,708 | 18,760 | ||||||||||||
Total operating expenses | 27,899 | 19,715 | 9,482 | 7,034 | 27,229 | ||||||||||||
Operating income | 14,374 | 935 | 4,512 | 1,513 | 3,022 | ||||||||||||
Financial and other income (expenses), net | (172 | ) | (292 | ) | (198 | ) | 16 | (320 | ) | ||||||||
Income before income taxes | 14,202 | 643 | 4,314 | 1,529 | 2,702 | ||||||||||||
Provision for income taxes | 374 | - | 104 | - | - | ||||||||||||
Net income | 13,828 | 643 | 4,210 | 1,529 | 2,702 | ||||||||||||
Net income per ordinary share: | |||||||||||||||||
Basic | 0.48 | 0.02 | 0.14 | 0.06 | 0.10 | ||||||||||||
Diluted | 0.46 | 0.02 | 0.13 | 0.06 | 0.10 | ||||||||||||
Weighted average number of ordinary shares | |||||||||||||||||
outstanding: | |||||||||||||||||
Basic | 28,823 | 27,218 | 30,111 | 27,253 | 27,253 | ||||||||||||
Diluted | 30,200 | 27,578 | 31,327 | 27,503 | 27,586 | ||||||||||||
6